Moors & Cabot, Inc. GSK PLC Transaction History

Moors & Cabot, Inc.

  • $2.02 Billion
  • Q4 2024
Number of Shares
26,610
Previous 26,999 1.44%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 07, 2025
SELL
N/A
-389 Reduced 1.44%
26,610 $0
Q3 2024

Nov 08, 2024
SELL
N/A
-255 Reduced 0.94%
26,999 $0
Q2 2024

Aug 09, 2024
BUY
N/A
1,559 Added 6.07%
27,254 $0
Q1 2024

May 08, 2024
SELL
N/A
-1,267 Reduced 4.7%
25,695 $0
Q4 2023

Feb 14, 2024
SELL
N/A
-1,783 Reduced 6.2%
26,962 $0
Q3 2023

Nov 07, 2023
SELL
N/A
-1,859 Reduced 6.07%
28,745 $0
Q2 2023

Aug 09, 2023
BUY
N/A
500 Added 1.66%
30,604 $0
Q1 2023

May 04, 2023
SELL
N/A
-1,080 Reduced 3.46%
30,104 $0
Q4 2022

Feb 09, 2023
BUY
N/A
31,184 New
31,184 $0
Q3 2022

Nov 07, 2022
BUY
N/A
31,340 New
31,340 $922,000
Track This Portfolio

Track Moors & Cabot, Inc. Portfolio

Follow Moors & Cabot, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Moors & Cabot, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Moors & Cabot, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email